Cisen Pharmaceutical Co., Ltd. (SHA:603367)

Market Cap	6.47B
Revenue (ttm)	4.25B
Net Income (ttm)	529.01M
Shares Out	452.75M
EPS (ttm)	1.17
PE Ratio	12.20
Forward PE	n/a
Dividend	0.44 (3.09%)
Ex-Dividend Date	Nov 22, 2024

Volume	4,802,400
Average Volume	3,435,938
Open	14.25
Previous Close	14.25
Day's Range	14.22 - 14.50
52-Week Range	11.70 - 17.45
Beta	0.28
RSI	66.70
Earnings Date	Apr 22, 2025

About Cisen Pharmaceutical

Cisen Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells chemical drug preparations and health care products in China and internationally. The company’s chemical drug preparations include liver disease drugs, antitumor and auxiliary drugs, nutrition preparations, contrast agents, antibiotics, digestive system agents, polypropylene ampoules, and external preparations, as well as sedation anesthesia, cardiovascular, cough and asthma, immunomodulator, infusion, and therapeutic infusion products. The company was former...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1998
• Employees: 3,402
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 603367

Financial Performance

In 2023, Cisen Pharmaceutical's revenue was 4.46 billion, an increase of 9.75% compared to the previous year's 4.07 billion. Earnings were 521.34 million, an increase of 48.97%.